Sipèentay ki genyen ant maladi bengwen manje ak maladi itilizasyon dwòg: Dyagnostik ak nerobyoloji (2013)

Ait-Daoud, N., Roache, JD, Dawes, MA, Liu, L., Wang, XQ., Javors, MA, Seneviratne, C. & Johnson, BA (2009): Èske serotipin transpò jenotip ka predi bzwen nan alkòl? Rechèch klinik eksperimantal sou Alkòl, NAN(8), 1329-1335.

Alger, SA, Schwalberg, MD, Bigaouette, JM, Michalek, AV & Howard, LJ (1991): Efè yon depresè tricyclic ak antagonist Opiate sou konpòtman repa egzajere nan normo-pwa bulimik ak obèz, sijè repa egzajere. Jounal Ameriken Nitrisyon nan Klinik, NAN(4), 865-871.

Asosyasyon Sikyatrik Ameriken (2013): Manyèl dyagnostik ak estatistik nan maladi mantal (5th ed.). Arlington, VA: Otè.

Anderson, JW, Greenway, FL, Fuijoka, K., Gadde, KM, McKenney, J. & O'Neil, PM (2002): Bupropion SR amelyore pèdi pwa: Yon 28-semèn doub-avèg, plasebo-kontwole jijman. Rechèch Obezite, NAN(7), 633-641.

Arbaizar, B., Dierssen-Sotos, T., Gómez-Acebo, I. & Llorca J. (2010): Topiramate nan tretman depandans alkòl: Yon meta-analiz. Aksyon Espanyòl nan psikyatri, KOUMAN POU, 8 12-.

Asin, KE, Davis, JD & Bednarz, L. (1992): efè diferans nan dwòg serotonèjik ak katecholaminèrjik sou konpòtman anjestif. Psychopharmocology (Bèlen), 109, 415 421-.

Avena, NM, Rada, P. & Hoebel, BG (2008): Prèv pou dejwe sik: efè konpòtman ak nerochimik nan tanzantan, konsomasyon sik twòp. Revizyon Neyozyans Syans Konpòtman, NAN, 20 39-.

Avena, NM, Rada, P. & Hoebel, BG (2009): sik ak grès binging gen diferans remakab nan konpòtman tankou depandans. Journal of Nutrition, 139(3), 623-628.

Baker, DA, McFarland, K., Lake, RW, Shen, H., Tang, XC, Toda, S. & Kalivas, PW (2003): Neuroadaptasyon nan echanj sistin-glutamat ki chita sou kokayin rplonje. Newoscience, NAN, 743 749-.

Balodis, IM, Molina, ND, Kober, H., Worhunsky, PD, White, MA, Sinha, R., Grilo, CM & Potenza, MN (2013): Divè substrats neral nan kontwòl inhibitory nan twoub manje repa egzajere relatif nan lòt manifestasyon nan obezite. Obezite, NAN(2), 367-377.

Brody, AL, Mandelkern, MA, Lee, G., Smith, E., Sadeghi, M., Saxena, S., Jarvik, ME & London, ED (2004): Atenuasyon nan cue-enkli bzwen sigarèt ak anterior cingulate cortical. deklanchman nan fimè bupropion trete: Yon etid preliminè. Rechèch Sikyatri, NAN, 269 281-.

Bulik, CM, Sullivan, PF & Kendler, KS (2002): medikal ak sikyatrik morbidite nan fanm obèz ak ak san manje repa egzajere. Jounal Entènasyonal pou Deranjman Alimantè yo, NAN(1), 72-78.

Cambridge, VC, Ziauddeen, H., Nathan, PJ, Subramaniam, N., Dodds, C., Chamberlain, SR, Koch, A., Maltby, K., Skeggs, AL, Napolitano, A., Farooqi, IS, Bullmore, ET & Fletcher, PC (2013): efè neral ak konpòtman nan yon nouvo antagonist reseptè opioid mu nan moun gra manje-obèz. Byolojik Sikyatri, NAN, 887 894-.

Cassin, SE & von Ranson, KM (2007): Èske manje repa egzajere kòm yon dejwe? Apeti, NAN(3), 687-690.

Chamberlain, SR, Mogg, K., Bradley, BP, Koch, A., Dodds, CM, Dao, WX, Maltby, K., Sarai, B., Napolitano, A., Richards, DB, Bullmore, ET & Nathan , PJ (2012): Efè antagonism reseptè opioid mu sou koyisyon nan moun ki obèz bingeeating. Psychopharmacology (Bèlen), 224(4), 501-509.

Claudino, AM, de Oliveira, IR, Appolinario, JC, Cordás, TA, Duchesne, M., Sichieri, R. & Bacaltchuk, J. (2007): Double-avèg, owaza, plasebo-kontwole jijman nan topiramate plis mantal konpòtman terapi nan twoub manje repa egzajere. Journal of Sikyatri nan klinik, NAN, 1324 1332-.

Corsica, JA & Spring, BJ (2008): Idrat kabòn bzwen: Yon doub-avèg, plasebo-kontwole tès ipotèz la oto-medikaman. Manje Konpòtman, NAN, 447 454-.

Cottone, P., Sabino, V., Steardo, L. & Zorrilla, EP (2008): Opioid-depandan antisipatif kontras negatif ak repa egzajere tankou nan rat ak aksè limite a manje trè pi pito. Neuropsychopharmacology, 33, 524 535-.

Davis, C. & Carter, JC (2009): twòp konpulsif kòm yon maladi dejwe: Yon revizyon nan teyori ak prèv. Apeti, NAN, 1 8-.

Davis, C., Curtis, C., Levitan, RD, Carter, JC, Kaplan, AS & Kennedy, JL (2011): Prèv ke 'dejwe manje' se yon fenotip ki valab nan obezite. Apeti, NAN, 711 717-.

Davis, CA, Levitan, RD, Reid, C., Carter, JC, Kaplan, AS, Patte, KA, King, N., Curtis, C. & Kennedy, JL (2009): Dopamine pou "vle" ak opioid pou "Senpati": Yon konparezon nan granmoun obèz ak ak san manje repa egzajere. Obezite, NAN, 1220 1225-.

Dingemans, AE, Bruna, MJ & van Furth, EF (2002): Maladi manje repa egzajere: Yon revizyon. Journal of Maladi ki gen rapò ak metabolis obezite, NAN, 299 307-.

Drewnowski, A., Krahn, DD, Demitrack, MA, Nairn, K. & Gosnell, BA (1995): Naloxone, yon blokaj opyat, diminye konsomasyon nan dous manje ki gen anpil grès nan moun ki gra ak mèg Manjè repa egzajere fi. Jounal Ameriken Nitrisyon nan Klinik, NAN, 1206 1212-.

Ferriter, C. & Ray, LA (2011): Manje repa egzajere ak repa egzajere bwè: Yon revizyon entegre. Manje Konpòtman, NAN, 99 107-.

Fortuna, JL (2012): epidemi obezite a ak adisyon manje: resanblans nan klinik ak depandans dwòg. Journal of Psychoactive Drugs, 44(1), 56-63.

Gadalla, T. & Piran, N. (2007): Ko-ensidan nan maladi manje ak maladi itilizasyon alkòl nan fanm: Yon meta analiz. Achiv nan Sante Mantal Fanm lan, KA, 133 140-.

Gadde, KM, Parker, CB, Maner, LG, Wagner, HR, 2nd, Logue, EJ, Drezner, MK & Krishnan, KR (2001): Bupropion pou pèdi pwa: Yon ankèt sou efikasite ak tolerabilite nan fanm ki twò gwo ak fanm obèz. Rechèch Obezite, NAN(9), 544-551.

Garbutt, JC, West, SL, Carey, TS, Lohr, KN & Crews, FT (1999): tretman farmakolojik nan depandans alkòl. Jounal Asosyasyon Medikal Ameriken an, 281, 1318 1325-.

Gearhardt, AN, Corbin, WR & Brownell, KD (2009): Preliminè validasyon nan echèl la dejwe Manje Yale. Apeti, NAN, 430 436-.

Gearhardt, AN, Blan, MA & Potenza, MN (2011): Twoub manje manje ak dejwe manje. Revizyon aktyèl abi dwòg, NAN, 201 207-.

Grant, JE, Potenza, MN, Weinstein, A. & Gorelick, DA (2010): Entwodiksyon nan depandans konpòtman. Jounal ameriken sou abi dwòg ak alkòl, 36, 233 241-.

Greenway, FL, Dunayevich, E., Tollefson, G., Erickson, J., Guttadauria, M., Fujioka, K. & Cowley, MA (2009): Konparezon nan bupropion konbine ak terapi naltrexone pou obezite withmonotherpay ak plasebo. Jounal nan nan klinik andokrinoloji ak metabolis, NAN(12), 4898-4906.

Grilo, CM, Blan, MA & Masheb, RM (2009): DSM-IV maladi sikyatrik komorbidite ak korelasyon li yo nan maladi manje repa egzajere. Jounal Entènasyonal pou Deranjman Alimantè yo, NAN, 228 234-.

Haltia, LT, Rinne, JO, Merisaari, H., Maguire, RP, Savontaus, E., Helin, S., Någren, K. & Kaasinen, V. (2007): Efè glikoz nan venn sou fonksyon dopaminerjik nan imen an sèvo nan vivo. Synapse, 61(9), 748-756.

Hommer, RE, Seo, D., Lacadie, CM, Chaplin, TM, Mayes, LC, Sinha, R. & Potenza, MN (2012): neral korelasyon nan estrès ak ekspozisyon pi renmen-replik manje nan adolesan: Yon fonksyonèl sonorite mayetik. etid D '. Transfòmasyon nan sèvo imen, Epub devan yo nan ekri an lèt detache, doi: 10.1007/s11947-011-0773-6

Hudson, JI, McElroy, SL, Raymond, NC, Crow, S., Keck, PE, Jr., Carter, WP, Mitchell, JE, Strakowski, SM, Pope, HG, Jr., Coleman, BS & Jonas, JM (1998): Fluvoxamine nan tretman pou maladi repa egzajere: Yon jijman multicenter plasebo-kontwole. Jounal Ameriken Sikyatri a, NAN, 1756 1762-.

Ifland, JR, Preuss, HG, Marcus, MT, Rourke, KM, Taylor, WC, Burau, K., Jacobs, WS, Kadish, W. & Manso, G. (2009): dejwe manje rafine: Yon itilizasyon sibstans klasik maladi. Hypotheses medikal, NAN, 518 526-.

Jain, AK, Kaplan, RA, Gadde, KM, Wadden, TA, Allison, DB, Brewer, ER, Leadbetter, RA, Richard, N., Haight, B., Jamerson, BD, Buaron, KS & Metz, A. (2002): Bupropion SR vs plasebo pou pèdi pwa nan pasyan obèz ki gen sentòm depresyon. Rechèch Obezite, NAN, 1049 1056-.

Johnson, PM & Kenny, PJ (2010): Dopamine D2 reseptè nan dejwe tankou malfonksyònman rekonpans ak manje konpulsif nan rat obèz. Nati Newoscience, NAN, 635 641-.

Jorenby, DE, Leischow, SJ, Nides, MA, Rennard, SI, Johnston, JA, Hughes, AR Smith, SS, Muramoto, ML, Daughton, DM, Doan, K., Fiore, MC & Baker, TB (1999) : Yon esè kontwole nan soutni lage bupropion, yon plak nikotin, oswa toude pou sispann fimen. New England Journal of Medsin, NAN, 685 691-.

Kessler, RC, Berglund, PA, Chiu, WT, Deitz, AC, Hudson, JI, Shahly, V., Aguilar-Gaxiola, S., Alonso, J., Angermeyer, MC, Benjet, C., Bruffaerts, R. , de Girolamo, G., de Graaf, R., Maria Haro, J., Kovess-Masfety, V., O'Neill, S., Posada-Villa, J., Sasu, C., Scott, K., Viana, MC & Xavier, M. (2013): prévalence la ak korelasyon nan maladi manje repa egzajere nan Sondaj Mondyal Sante Mantal Organizationganizasyon Mondyal la. Byolojik Sikyatri, NAN, 904 914-.

Wa, AC, Cao, D., Zhang, L. & O'Malley, SS (2013): rediksyon Naltrexone nan alontèm pran pwa fimen sispann nan fanm, men se pa gason: Yon owaza esè kontwole. Byolojik Sikyatri, NAN, 924 930-.

Koob, GF & Le Moal, M. (2001): dejwe dwòg, dysregulation nan rekonpans, ak allostatis. Neuropsychopharmacology, 24, 97 129-.

Lewinsohn, PM, Seeley, JR, Moerk, KC & Striegel-Moore, RH (2002): Diferans sèks nan sentòm maladi manje nan jèn adilt yo. Creole Journal of Eating Disorders, 32, 426 440-.

Lilenfeld, LRR, Ringham, R., Kalarchian, MA & Marcus, MD (2008): Yon etid istwa familyal nan maladi repa egzajere. Sikyatri Comprehensive, NAN, 247 254-.

Luce, KH, Engler, PA & Crowther, JH (2007): Maladi manje ak itilizasyon alkòl: Gwoup diferans nan pousantaj konsomasyon ak motif bwè. Manje Konpòtman, NAN, 177 184-.

Maldonado-Irizarry, CS, Swanson, CJ & Kelley, AE (1995): reseptè Glutamate nan nwayo accumbens koki kontwòl konpòtman manje via ipotalamus lateral la. Journal of Newoscience, NAN, 6779 6788-.

Marrazzi, MA, Markham, KM, Kinzie, J. & Luby, ED (1995): Maladi manje repa egzajere: Repons a naltrexone. Jounal entènasyonal la sou obezite ak Maladi Metabolism ki gen rapò ak, NAN(2), 143-145.

McElroy, SL, Arnold, LM, Shapira, NA, Keck, PE, Jr., Rosenthal, NR, Karim, MR, Kamin, M. & Hudson, JI (2003): Topiramate nan tretman twoub repa egzajere ki asosye avèk obezite. : Yon owaza, plasebo-kontwole jijman. Jounal Ameriken Sikyatri a, NAN, 255 261-.

McElroy, SL, Casuto, LS, Nelson, EB, Lake, KA, Soutullo, CA, Keck, PE, Jr. & Hudson, JI (2000): Plasbo-kontwole jijman sertralin nan tretman maladi twoub binge. Jounal Ameriken Sikyatri a, NAN, 1004 1006-.

McElroy, SL, Guerdjikova, AI, Mori, N. & O'Melia, AM (2012): famasi jesyon maladi repa egzajere: opsyon tretman aktyèl ak émergentes. Therapeutics ak nan klinik Risk Jesyon, 8, 219 241-.

McElroy, SL, Guerdjikova, AI, Winstanley, EL, O'Melia, AM, Mori, N., McCoy, J., Keck, PE & Hudson, JI (2011): Acamprosate nan tretman maladi twoub manje: Yon plasebo -prosè kontwole. Jounal Entènasyonal pou Deranjman Alimantè yo, NAN, 81 90-.

McElroy, SL, Hudson, JI, Capece, JA, Beyers, K., Fisher, AC, Rosenthal, NR & Topiramate Binge Manje Rechèch Gwoup Rechèch (2007): Topiramate pou tretman pou maladi manje repa egzajere ki asosye ak obezite: Yon plasebo-. etid kontwole. Byolojik Sikyatri, NAN, 1039 1048-.

Merikangas, KR & McClair, VL (2012): Epidemyoloji nan maladi itilizasyon sibstans. Imèn Jenetik, KA NAN, 779 789-.

Meyer, F. (2008): Amelyorasyon tou de dòz manje fè manje ak malfonksyònman seksyèl ak naltrexòn. Journal of psikofarmakoloji nan klinik, NAN(6), 722-723.

Miller, PM, Liv, SW & Stewart, SH (2011): Tretman medikal nan depandans alkòl: Yon revizyon sistematik. Jounal Entènasyonal Medsin Sikyatri a, NAN(3), 227-266.

Myers, KM, Carlezon, WA, Jr. & Davis, M. (2011): reseptè Glutamate nan disparisyon ak terapi disparisyon ki baze sou pou maladi sikyatrik. Neuropsychopharmacology, 36, 274 293-.

Neumeister, A., Winkler, A. & Wober-Bingol, C. (1999): Anplis de sa nan naltrexone fluoksetin nan tretman pou maladi manje repa egzajere. Jounal Ameriken Sikyatri a, NAN(5), 797.

Rabiner, EA, Beaver, J., Makwana, A., Searle, G., Long C., Nathan, PJ, Newbould, RD, Howard, J., Miller, SR, Bush, MA, Hill, S., Reiley , R., Passchier, J., Gunn, RN, Matthews, PM & Bullmore, ET (2011): Famakolojik diferansyasyon antagonis reseptè opioid pa D molekilè ak fonksyonèl nan lokatè sib ak rekonpans manje ki gen rapò ak aktivasyon nan sèvo nan imen. Molekilè Sikyatri, KA NAN, 826 835-.

Schaechter, JD & Wurtman, RJ (1990): Serotonin lage varye ak nivo triptofan nan sèvo. Rechèch nan sèvo, NAN, 203 210-.

Sheng, LX, Tang, YL, Jiang, ZN, Yao, CH, Gao, JY, Xu, GZ & Tong, XY (2013): bupropion soutni-lage pou sispann fimen nan echantiyon Chinwa: Yon doub-avèg, plasebo-kontwole , jijman owaza. Nikotin & Tabak Rechèch, 15(2), 320-325.

Sim, LA, McAlpine, DE, Grothe, KB, Himes, SM, Cockerill, RG & Clark, MM (2010): Idantifikasyon ak tretman maladi manje nan anviwònman swen prensipal la. Pwosedi Klinik Mayo, NAN, 746 751-.

Smith, DG & Robbins, TW (2013): nerobyolojik anba-penn yo nan obezite ak manje repa egzajere: Yon rezon pou adopte modèl la dejwe manje. Byolojik Sikyatri, NAN(9), 804-810.

Snyder, JL & Bowers, TG (2008): efikasite nan acamprosate ak naltrexone nan tretman depandans alkòl: Yon analiz relatif benefis nan esè kontwole owaza. Jounal ameriken sou abi dwòg ak alkòl, 34, 449 461-.

Spring, B., Wurtman, J., Gleason, R. & Kessler, K. (1991): Pran pwa ak sentòm retrè apre sispann fimen: Yon entèvansyon prevantif lè l sèvi avèk d-fenfluramin. Sikoloji Sante, NAN, 216 223-.

Tanofsky-Kraff, M., Bulik, CM, Marcus, MD, Striegel, RH, Wilfley, DE, Wonderlich, SA & Hudson, JI (2013): Maladi manje repa egzajere: pwochen jenerasyon rechèch la. Jounal Entènasyonal pou Deranjman Alimantè yo, NAN, 193 207-.

Tata, AL & Kockler, DR (2006): Topiramate pou maladi repa egzajere ki asosye ak obezite. Istwa a nan Farmako-terapi, NAN(11), 1993-1997.

Thanos, PK, Bermeo, C., Wang GJ & Volkow, ND (2011): Bromokriptin ogmante opere reponn pou manje ki gen anpil grès men diminye konsomasyon chow nan tou de rat obezite ki gen tandans ak rezistan. Rechèch nan konpòtman nan sèvo, NAN, 165 170-.

Van den Brink, W. (2012): prèv ki baze sou tretman famasi nan itilizasyon sibstans maladi ak jwèt aza pathologie. Revizyon aktyèl abi dwòg, NAN, 3 31-.

Volkow, ND, Wang, GJ, Telang, F., Fowler, JS, Thanos, PK, Logan, J., Alexoff, D., Ding, YS, Wong, C., Ma, Y. & Pradhan, K. ( 2008): Low dopamine striatal D2 reseptè yo asosye avèk prefrontalmetabolism nan sijè obèz: faktè posib kontribye. Neuroimaj, NAN(4), 1537-1543.

Volkow, ND, Wang, GJ, Tomasi, D. & Baler, RD (2013): Obezite ak dejwe: sipèpoze nerobyolojik. Obezite Revizyon, NAN, 2 18-.

Wang, GJ, Geliebter, A., Volkow, ND, Telang, FW, Logan, J., Jayne, MC, Galanti, K., Selig, PA, Han, H., Zhu, W., Wong, CT & Fowler , JS (2011): Amelyore dopamine striatal lage pandan eksitasyon manje nan twoub manje repa egzajere. Obezite, NAN, 1601 1608-.

Wang, GJ, Volkow, ND, Logan, J., Pappas, NR, Wong, CT, Zhu, W., Netusil, N. & Fowler, JS (2001): Dopamine nan sèvo ak obezite. Lancet, NAN, 354 357-.

Wang, GJ, Volkow, ND, Thanos, PK & Fowler, JS (2004): resanblans ant obezite ak dejwe dwòg jan evalye pa imajinasyon nerofonksyonèl: Yon revizyon konsèp. Journal of Twoub depandans, NAN, 39 53-.

Blan, MA & Grilo, CM (2013): Bupropion pou fanm ki twò gwo ki gen maladi repa egzajere: Yon owaza, doub-avèg, plasebo-kontwole jijman. Journal of Clinical Psychiatry, 74(4), 400-406.

Wise, RA (2004): Rekonpans te vle: mekanism molekilè nan motivasyon. Dekouvèt Medsin, NAN, 180 186-.

Zhang, M., Gosnell, BA & Kelley, AE (1998): Se konsomasyon nan manje ki gen anpil grès oaza ranfòse pa eksitasyon reseptè opioid mu nan nwayo accumbens la. Journal of Pharmacology and Experimental Therapeutics, 285, 908 914-.

Ziauddeen, H., Farooqi, IS & Fletcher, PC (2012): Obezite ak sèvo a: Ki jan konvenkan se modèl la dejwe. Nati Reviews Neuroscience, 13, 279 286-.

Ziauddeen, H. & Fletcher, PC (2012): Èske dejwe manje yon konsèp valab epi itil? Obezite Kòmantè, NAN, 19 28-.